CAR-T Therapy Versus Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: Systematic Review and Metanalysis of Toxicity and Response

被引：0
|
作者：
Mehta, Mansi [1 ]
Namjoshi, Devang [1 ]
Fernandes, Bolivia Crocete Aloysia [2 ,3 ]
Mukhtiar, Vaibhavi [1 ]
Bhanushali, Charmi [1 ]
Kumar, Madhan Srinivasan [4 ]
Rana, Gunjan [1 ]
Santhi, Jaison Lawrence Alexander [5 ]
Mishra, Tanisha [6 ]
Ramanathan, Muthalagu [7 ,8 ]
机构：
[1] St Vincent Hosp, Worcester, MA, Brazil
[2] St Marys Gen Hosp, New York Med Coll, Grad Med Educ Program, Denville, NJ USA
[3] St Clares Hlth, Denville, NJ USA
[4] St Vincent Hosp, Internal Med, Worcester, MA, Brazil
[5] Mercy Catholic Med Ctr, Aldan, PA USA
[6] Manipal Acad Higher Educ, Kasturba Med Coll, Manipal, India
[7] Univ Massachusetts, Mem Med Ctr, Dept Med, Div Hematol Oncol, Worcester, MA, Brazil
[8] UMass Mem Med Ctr, Div Stem Cell Transplantat, Worcester, MA, Brazil
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-206207
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6929 / 6930
页数：2
相关论文
共 50 条
  • [21] Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
    Su, Christopher T.
    Ye, J. Christine
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [22] High efficacy and safety of CD38 and BCMA bispecific CAR-T in relapsed or refractory multiple myeloma
    Tang, Yuanyan
    Yin, Haisen
    Zhao, Xinying
    Jin, Dan
    Liang, Yan
    Xiong, Tao
    Li, Lu
    Tang, Wen
    Zhang, Jiangzhao
    Liu, Min
    Yu, Zhuojun
    Liu, Huimin
    Zang, Sibin
    Huang, Zhiping
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [23] Infectious Complications during Treatment with Commercial CAR T-Cell Therapy and Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma
    Jurgens, Eric M.
    Shekarkhand, Tala
    Farzana, Tasmin
    Rueda, Colin
    Nemirovsky, David
    Derkach, Andriy
    Firestone, Ross S.
    Nishimura, Noriko
    Miller, Kevin
    Costa, Bruno Almeida
    Nath, Karthik
    Rajeeve, Sridevi
    Lesokhin, Alexander M.
    Korde, Neha
    Tan, Carlyn Rose
    Hashmi, Hamza
    Hassoun, Hani
    Maclachlan, Kylee H.
    Shah, Urvi A.
    Hultcrantz, Malin
    Hamadeh, Issam S.
    Giralt, Sergio A.
    Chung, David J.
    Landau, Heather J.
    Scordo, Michael
    Shah, Gunjan L.
    Usmani, Saad Z.
    Mailankody, Sham
    Shahid, Zainab
    BLOOD, 2024, 144 : 6935 - 6936
  • [24] Sequencing of Bispecific Antibodies in Relapsed Refractory Multiple Myeloma
    Shewan, Samuel
    Steinbach, Mary
    Julian, Kelley
    Fortuna, Gliceida Galarza
    Vigil, Meghan
    Maxwell, Linsday
    Parkin, Eliza
    Wagner, Charlotte
    Mohyuddin, Manni
    Godara, Amandeep
    McClune, Brian
    Sborov, Douglas W.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S88 - S88
  • [25] Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma
    Tacchetti, Paola
    Barbato, Simona
    Mancuso, Katia
    Zamagni, Elena
    Cavo, Michele
    CANCERS, 2024, 16 (13)
  • [26] T-cell redirected bispecific antibodies in relapsed and refractory multiple myeloma: A systematic review and meta-analysis.
    Bin Waqar, Syed Hamza
    Khanam, Razwana
    Rehman, Mohammad Ebad Ur
    Chattaraj, Asmi
    Ali, Hassam
    Anwer, Faiz
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Strategies for salvage therapy post CAR-T therapy failure in refractory/relapsed multiple myeloma patients
    Min, Chao
    Zhong, Xiong
    Cui, Yue
    Zhang, Hanfu
    Wang, Qingming
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [28] Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
    Ma, Ruixue
    Zhang, Qi
    Liu, Yang
    Li, Hujun
    Chen, Huimin
    Zhang, Qianqian
    Qiao, Jianlin
    Qi, Kunming
    Shen, Guifang
    Sun, Cai
    Song, Xuguang
    Cao, Jiang
    Cheng, Hai
    Zhu, Feng
    Yan, Zhiling
    Sang, Wei
    Li, Depeng
    Sun, Haiying
    Zheng, Junnian
    Li, Zhenyu
    Xu, Kailin
    Chen, Wei
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [29] Safety and Efficacy of Anti-Bcma CAR-T Cells for Relapsed/Refractory Multiple Myeloma: A Systematic Review of Literature
    Khan, Israr
    Rafae, Abdul
    Javaid, Anum
    Ahmed, Zahoor
    Qadeer, Haifza Abeera
    Khan, Sana Irfan
    Dar, Abdul Jabbar
    Khurshid, Qasim
    Jaan, Ali
    Khalid, Farhan
    Aijaz, Zobia
    Hashmi, Mydah Sajid
    Malik, Mustafa Nadeem
    Anwer, Faiz
    BLOOD, 2020, 136
  • [30] Overview of anti-BCMA CAR-T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma
    Feng, Deming
    Sun, Jian
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (02)
12345